Medifast (NYSE:MED) OPTAVIA System Now Reimbursable on Select Insurance Plans

2026-02-20, 6:32:17 a.m.

February 20, 2026 — Leads & Copy — OPTAVIA’s comprehensive metabolic health system is now reimbursable on select insurance plans using Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA), Medifast® (NYSE: MED) announced today.

OPTAVIA clients may be able to save up to 40% on program costs by working with their medical provider and insurance administrator to use pre-tax medical funds. This offers accessibility for those prioritizing their metabolic health.

Nicholas Johnson, President of Medifast, said this is a major moment for the company, and more importantly, for the millions of people across the U.S. seeking solutions for improving their health. He added that with OPTAVIA’s metabolic health system available on select insurance plans using HSA and FSA funds, the company is encouraging more people to access the innovative tools and science-backed solutions they need to help promote metabolic health.

This milestone reinforces Medifast’s position as a science-driven health and wellness leader, with a metabolic reset plan that reverses metabolic dysfunction. The company said that more than 90% of U.S. adults are classified as metabolically unhealthy. OPTAVIA is designed to address these challenges head-on, combining a science-backed system with coaching to guide clients toward improvements in their metabolic health, targeting the root cause of metabolic dysfunction.

OPTAVIA’s approach is rooted in Metabolic Synchronization™, which resets the body’s metabolism through healthy, quality weight loss, targeting visceral fat reduction, preserving lean mass and protecting healthy muscle.

Dr. Satya Jonnalagadda, Vice President of Scientific & Clinical Affairs at Medifast, said that with Metabolic Synchronization, the company is empowering individuals to take control of their metabolic health. She added that their science-backed solutions achieve more than just weight loss — they improve body composition by reducing visceral fat, preserving lean mass and protecting healthy muscle, which are critical to restoring metabolic balance.

Using the science of Metabolic Synchronization, Medifast plans to launch a new system in 2026 featuring products that incorporate clinically studied ingredients designed to further support metabolic health, marking the next step in the company’s ongoing commitment to providing solutions that adapt to every stage of the health journey.

Medifast (NYSE: MED) is the health and wellness company known for its science-backed, coach-guided lifestyle system. Designed to address the challenges of metabolic dysfunction, the company’s holistic approach integrates personalized plans, scientifically developed products and a framework for sustainable habit creation — all supported by a dedicated network of independent coaches.

Driven to improve metabolic health through advanced science and comprehensive behavioral support, Medifast has introduced Metabolic Synchronization™, a breakthrough science that reverses metabolic dysfunction through targeted metabolic reset. Research demonstrates that the company’s comprehensive system activates strong and targeted fat burning to enhance metabolic health and body composition by reducing visceral fat, preserving lean mass and protecting muscle integrity.

Backed by more than 40 years of clinical heritage, Medifast continues to advance its mission of Lifelong Transformation, Making a Healthy Lifestyle Second Nature®.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.